Skip to content
2000
image of Prognostic Effects of Platelet Reactivity in Patients with Carotid Artery Stenting or Carotid Artery Endarterectomy: A Systematic Review and Meta-Analysis

Abstract

Introduction

High On-Treatment Platelet Reactivity (HTPR) is frequently observed after carotid endarterectomy (CEA) or stenting (CAS), but its association with adverse events remains uncertain. This systematic review and meta-analysis evaluate the association between HTPR and recurrent vascular events in these patients.

Methods

EMBASE, PubMed, and Cochrane Library were searched for eligible studies from inception to July 1, 2024. Two independent reviewers screened the records, extracted data, and assessed the bias using predefined criteria. A meta-analysis was conducted using RevMan 5.4 software. The primary outcome was the risk of recurrent ischemic events in patients with HTPR. Secondary outcomes included the risk of hemorrhage and carotid restenosis.

Results

Eight studies involving 1,052 patients were included in the meta-analysis. This meta-analysis found that HTPR significantly increased the risk of adverse vascular events (OR = 2.41, 95% CI: 1.37-4.24), particularly in CAS patients (OR = 1.85, 95% CI: 1.14-2.98), but not in CEA patients (OR = 4.53, 95% CI: 0.52-39.12). Furthermore, HTPR was not significantly associated with an increased risk of bleeding (OR = 0.90, 95% CI: 0.24-3.37) or carotid restenosis (OR = 1.70, 95% CI: 0.38-7.55).

Discussion

This meta-analysis demonstrates that HTPR may increase the risk of recurrent ischemic events in CAS patients, supporting the clinical utility of platelet function monitoring in this population. However, no significant association was observed between HTPR and hemorrhage or restenosis. These findings should be interpreted cautiously due to study limitations, including small sample sizes and heterogeneity in platelet function assessment methodologies. Large-scale prospective studies with standardized protocols are warranted to validate these observations.

Conclusion

HTPR may be associated with an increased risk of recurrent ischemic events in patients undergoing CAS, highlighting the potential value of platelet function monitoring.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnr/10.2174/0115672026395463250822065302
2025-08-27
2025-10-31

  • From This Site

    /content/journals/cnr/10.2174/0115672026395463250822065302
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Rajagopalan S. Mckay I. Ford I. Bachoo P. Greaves M. Brittenden J. Platelet activation increases with the severity of peripheral arterial disease: Implications for clinical management. J. Vasc. Surg. 2007 46 3 485 490 10.1016/j.jvs.2007.05.039 17826235
    [Google Scholar]
  2. Zhou K. Yu S. Li J. High on‐treatment platelet reactivity is associated with poor outcomes after ischemic stroke: A meta‐analysis. Acta Neurol. Scand. 2022 146 3 205 224 10.1111/ane.13655 35652290
    [Google Scholar]
  3. Gurbel P.A. Becker R.C. Mann K.G. Steinhubl S.R. Michelson A.D. Platelet function monitoring in patients with coronary artery disease. J. Am. Coll. Cardiol. 2007 50 19 1822 1834 10.1016/j.jacc.2007.07.051 17980247
    [Google Scholar]
  4. Montenont E. Echagarruga C. Allen N. Araldi E. Suarez Y. Berger J.S. Platelet WDR1 suppresses platelet activity and is associated with cardiovascular disease. Blood 2016 128 16 2033 2042 10.1182/blood‑2016‑03‑703157 27609643
    [Google Scholar]
  5. Rao Z. Zheng H. Wang F. The association between high on-treatment platelet reactivity and early recurrence of ischemic events after minor stroke or TIA. Neurol. Res. 2017 39 8 719 726 10.1080/01616412.2017.1312793 28398139
    [Google Scholar]
  6. Lv H. Yang Z. Wu H. High on-treatment platelet reactivity as predictor of long-term clinical outcomes in stroke patients with antiplatelet agents. Transl. Stroke Res. 2022 13 3 391 398 10.1007/s12975‑021‑00949‑7 34596891
    [Google Scholar]
  7. Shaik N.F. Regan R.F. Naik U.P. Platelets as drivers of ischemia/reperfusion injury after stroke. Blood Adv. 2021 5 5 1576 1584 10.1182/bloodadvances.2020002888 33687431
    [Google Scholar]
  8. Braunwald E Angiolillo D Bates E Assessing the current role of platelet function testing. Clin Cardiol 2008 31 S1 I10 I16.(Suppl. 1) 10.1002/clc.20361 18481816
    [Google Scholar]
  9. Gurbel P.A. Bliden K.P. Hiatt B.L. O’Connor C.M. Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003 107 23 2908 2913 10.1161/01.CIR.0000072771.11429.83 12796140
    [Google Scholar]
  10. Galli M. Terracina S. Schiera E. Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: Results from a large tertiary care hospital. J. Thromb. Thrombolysis 2024 58 1 71 83 10.1007/s11239‑024‑03022‑w 39242457
    [Google Scholar]
  11. Grotemeyer K.H. Scharafinski H.W. Husstedt I.W. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb. Res. 1993 71 5 397 403 10.1016/0049‑3848(93)90164‑J 8236166
    [Google Scholar]
  12. Jeon S.B. Song H.S. Kim B.J. Biochemical aspirin resistance and recurrent lesions in patients with acute ischemic stroke. Eur. Neurol. 2010 64 1 51 57 10.1159/000315147 20606449
    [Google Scholar]
  13. Busch L. Stern M. Dannenberg L. Impact of high on-treatment platelet reactivity after angioplasty in patients with peripheral arterial disease. Platelets 2021 32 3 391 397 10.1080/09537104.2020.1742314 32252582
    [Google Scholar]
  14. Yang B. Ma Y. Wang T. Carotid endarterectomy and stenting in a chinese population: Safety outcome of the revascularization of extracranial carotid artery stenosis trial. Transl. Stroke Res. 2021 12 2 239 247 10.1007/s12975‑020‑00835‑8 32686047
    [Google Scholar]
  15. Fu H. Hu P. Ma C. Peng F. He Z. Association of clopidogrel high on-treatment reactivity with clinical outcomes and gene polymorphism in acute ischemic stroke patients. Medicine (Baltimore) 2020 99 15 e19472 10.1097/MD.0000000000019472 32282698
    [Google Scholar]
  16. Fiolaki A. Katsanos A.H. Kyritsis A.P. High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: A systematic review and meta-analysis. J. Neurol. Sci. 2017 376 112 116 10.1016/j.jns.2017.03.010 28431593
    [Google Scholar]
  17. Wells G.A. Shea B. O’Connell D. Peterson J. Welch V. Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  18. Ball S.T.E. Taylor R. McCollum C.N. Resistance to antiplatelet therapy is associated with symptoms of cerebral ischemia in carotid artery disease. Vasc. Endovascular Surg. 2020 54 8 712 717 10.1177/1538574420947235 32856558
    [Google Scholar]
  19. Ciolli L. Lelli N. Rosafio F. Platelet function monitoring performed after carotid stenting during endovascular stroke treatment predicts outcome. J. Stroke Cerebrovasc. Dis. 2021 30 7 105800 10.1016/j.jstrokecerebrovasdis.2021.105800 33964545
    [Google Scholar]
  20. González A. Moniche F. Cayuela A. Gonzalez-Marcos J.R. Mayol A. Montaner J. Antiplatelet effects of clopidogrel dose adjustment (75 mg/d vs 150 mg/d) after carotid stenting. J. Vasc. Surg. 2014 60 2 428 435 10.1016/j.jvs.2014.01.068 24629989
    [Google Scholar]
  21. Muram S. Panchendrabose K. Eagles M.E. Natural history of antiplatelet nonresponders undergoing carotid artery stenting. J. Neurosurg. 2023 139 3 661 669 10.3171/2022.12.JNS222316 36708530
    [Google Scholar]
  22. Nishi H. Nakahara I. Matsumoto S. Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy. J. Neurointerv. Surg. 2016 8 9 949 953 10.1136/neurintsurg‑2015‑011844 26297788
    [Google Scholar]
  23. Simonte G. Guglielmini G. Falcinelli E. High-on-treatment platelet reactivity predicts adverse outcome after carotid artery stenting: A prospective study. Thromb. Res. 2023 222 117 123 10.1016/j.thromres.2022.12.015 36640567
    [Google Scholar]
  24. Yoshimura M. Sumita K. Fujii S. Periprocedural variability of platelet functions in carotid artery stenting: An analysis using verifynow. J Neuroendovasc Ther 2021 15 8 505 516 10.5797/jnet.oa.2020‑0170 37502767
    [Google Scholar]
  25. Lewszuk A. Staszkiewicza W. Madycki G. Słowiński P. Evaluation of platelet activity and incidence of resistance to acetylsalicylic acid in patients receiving thrombosis prevention after carotid endarterectomy. Acta Angiologica 2012 18 2 68 78
    [Google Scholar]
  26. Chinda B. Tran K.H. Doesburg S. Functional MRI evaluation of cognitive effects of carotid stenosis revascularization. Brain Behav. 2022 12 4 e2512 10.1002/brb3.2512 35233977
    [Google Scholar]
  27. Fuse Y. Kojima T. Shintai K. Seki Y. Long-term outcomes of carotid artery stenting: A single-center experience. Neurol. Med. Chir. (Tokyo) 2020 60 3 121 125 10.2176/nmc.oa.2019‑0192 31902874
    [Google Scholar]
  28. Nakagawa I Kotsugi M Yokoyama S Antithrombotic therapy in carotid artery and intracranial artery stent. J Neuroendovasc Ther 2025 19 1 ra.2024-0014 10.5797/jnet.ra.2024‑0014 40007971
    [Google Scholar]
  29. Qaja E. Tadi P. Theetha Kariyanna P. Symptomatic Carotid Artery Stenosis. StatPearls. StatPearls Publishing 2025
    [Google Scholar]
  30. Stefanini M. Gaspari E. Boi L. Correlation between US-PSV and 64-Row MDCTA with advanced vessel analysis in the quantification of 50–70% carotid artery stenosis. Int. J. Vasc. Med. 2012 2012 1 8 10.1155/2012/928638 22577554
    [Google Scholar]
  31. Che F. Mi D. Wang A. Extracranial carotid plaque hemorrhage predicts ipsilateral stroke recurrence in patients with carotid atherosclerosis: A study based on high-resolution vessel wall imaging MRI. BMC Neurol. 2022 22 1 237 10.1186/s12883‑022‑02758‑3 35764942
    [Google Scholar]
  32. Kelly P.J. Camps-Renom P. Giannotti N. Carotid plaque inflammation imaged by 18 F-fluorodeoxyglucose positron emission tomography and risk of early recurrent stroke. Stroke 2019 50 7 1766 1773 10.1161/STROKEAHA.119.025422 31167623
    [Google Scholar]
  33. Jiang H. Zeng Q. Jiang W. Carotid-cavernous sinus fistula with primary clinical manifestation of cerebral infarction: Description of two cases. Quant. Imaging Med. Surg. 2023 13 3 2021 2025 10.21037/qims‑22‑613 36915300
    [Google Scholar]
  34. Kim M.J. Ha S.K. Outcomes following carotid endarterectomy and carotid artery stenting in patients with carotid artery stenosis: A retrospective study from a single center in South Korea. Med. Sci. Monit. 2023 29 e939223 10.12659/MSM.939223 36788720
    [Google Scholar]
  35. Duconge J. Hernandez-Suarez D.F. Potential usefulness of clopidogrel pharmacogenetics in ce rebral endovascular procedures and carotid artery stenting. Curr. Clin. Pharmacol. 2017 12 1 11 17 10.2174/1574884712666170227154654 28245774
    [Google Scholar]
  36. Hrbáč T. Fiedler J. Procházka V. Comparison of carotid endarterectomy and repeated carotid angioplasty and stenting for in-stent restenosis (CERCAS trial): A randomised study. Stroke Vasc. Neurol. 2023 8 5 399 404 10.1136/svn‑2022‑002075 36972920
    [Google Scholar]
  37. Bandyk D.F. Follow-up after carotid endarterectomy and stenting: What to look for and why. Semin. Vasc. Surg. 2020 33 3-4 47 53 10.1053/j.semvascsurg.2020.11.001 33308595
    [Google Scholar]
  38. Bonello L. Mancini J. Pansieri M. Relationship between post‐treatment platelet reactivity and ischemic and bleeding events at 1‐year follow‐up in patients receiving prasugrel. J. Thromb. Haemost. 2012 10 10 1999 2005 10.1111/j.1538‑7836.2012.04875.x 22863374
    [Google Scholar]
  39. Texakalidis P. Giannopoulos S. Kokkinidis D.G. Karasavvidis T. Rangel-Castilla L. Reavey-Cantwell J. Carotid artery endarterectomy versus carotid artery stenting for patients with contralateral carotid occlusion: A systematic review and meta-analysis. World Neurosurg. 2018 120 563 571.e3 10.1016/j.wneu.2018.08.183 30189300
    [Google Scholar]
  40. Mao Y. Zhu B. Wen H. Zhong T. Bian M. Impact of platelet hyperreactivity and diabetes mellitus on ischemic stroke recurrence: A single-center cohort clinical study. Int. J. Gen. Med. 2024 17 1127 1138 10.2147/IJGM.S450059 38544974
    [Google Scholar]
  41. Goncalves L.N. van Velze V. Klok F.A. Gal P. Vos R.C. Hamming J.F. High on-treatment platelet reactivity in peripheral arterial disease: A systematic review. Vascular 2023 17085381231214324 10.1177/17085381231214324 37950666
    [Google Scholar]
  42. Noh K.C. Choi H. Woo H.G. High-on-aspirin platelet reactivity differs between recurrent ischemic stroke associated with extracranial and intracranial atherosclerosis. J. Clin. Neurol. 2022 18 4 421 427 10.3988/jcn.2022.18.4.421 35796267
    [Google Scholar]
  43. Wen M. Li Y. Qu X. Comparison of platelet reactivity between prasugrel and ticagrelor in patients with acute coronary syndrome: A meta-analysis. BMC Cardiovasc. Disord. 2020 20 1 430 10.1186/s12872‑020‑01603‑0 33004000
    [Google Scholar]
  44. Čolić M.D. Čalija B.M. Milosavljević B.M. Low on‐treatment platelet reactivity predicts long‐term risk of bleeding after elective PCI. J. Interv. Cardiol. 2015 28 6 531 543 10.1111/joic.12251 26643001
    [Google Scholar]
  45. Aradi D. Kirtane A. Bonello L. Bleeding and stent thrombosis on P2Y 12 -inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur. Heart J. 2015 36 27 1762 1771 10.1093/eurheartj/ehv104 25896078
    [Google Scholar]
  46. Gruttemeier J. Cottin Y. Yao H. Impact of platelet reactivity in ACS patients on clinical outcomes with triple antithrombotic therapy. J. Clin. Med. 2021 10 8 1565 10.3390/jcm10081565 33917717
    [Google Scholar]
  47. Sibbing D. Steinhubl S.R. Schulz S. Schömig A. Kastrati A. Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: Initial evidence of a therapeutic window. J. Am. Coll. Cardiol. 2010 56 4 317 318 10.1016/j.jacc.2010.03.048 20633826
    [Google Scholar]
  48. Michelson A.D. Frelinger A.L. Furman M.I. Current options in platelet function testing. Am. J. Cardiol. 2006 98 10 S4 S10 10.1016/j.amjcard.2006.09.008 17097417
    [Google Scholar]
  49. Larsen J.B. Hvas A.M. Hojbjerg J.A. Platelet function testing: Update and future directions. Semin. Thromb. Hemost. 2023 49 6 600 608 10.1055/s‑0042‑1757898 36384230
    [Google Scholar]
  50. Gebetsberger J. Prüller F. Classic light transmission platelet aggregometry: Do we still need it? Hamostaseologie 2024 44 4 304 315 10.1055/a‑2117‑4614 38065556
    [Google Scholar]
/content/journals/cnr/10.2174/0115672026395463250822065302
Loading
Prognostic Effects of Platelet Reactivity in Patients with Carotid Artery Stenting or Carotid Artery Endarterectomy: A Systematic Review and Meta-Analysis
Bentham Science Publishers ; https://doi.org/10.2174/0115672026395463250822065302
/content/journals/cnr/10.2174/0115672026395463250822065302
/content/journals/cnr/10.2174/0115672026395463250822065302
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keywords: HTPR ; CEA ; Carotid artery stenting ; carotid artery endarterectomy ; CAS ; platelet reactivity

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test